ChemPartner PharmaTech Co Ltd (300149) — Financial Flexibility Index
ChemPartner PharmaTech Co Ltd (300149) has a Financial Flexibility Index of 0.09x as of June 2023. Free cash flow of CN¥94.83 Million (operating CF CN¥28.21 Million minus capex CN¥66.62 Million) represents 0% of total liabilities (CN¥1.06 Billion). Check 300149 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ChemPartner PharmaTech Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for ChemPartner PharmaTech Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see 300149 cash flow conversion.
Annual Financial Flexibility Index for ChemPartner PharmaTech Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for ChemPartner PharmaTech Co Ltd. Explore debt repayment capacity of ChemPartner PharmaTech Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥252.97 Million | CN¥190.50 Million | CN¥732.59 Million | ▲ +10.2% |
| 2024 | 0.31x | CN¥237.45 Million | CN¥168.21 Million | CN¥757.75 Million | ▼ -13.4% |
| 2023 | 0.36x | CN¥352.28 Million | CN¥150.99 Million | CN¥973.44 Million | ▼ -13.1% |
| 2022 | 0.42x | CN¥598.66 Million | CN¥262.46 Million | CN¥1.44 Billion | ▲ +39.7% |
| 2021 | 0.30x | CN¥664.22 Million | CN¥378.22 Million | CN¥2.23 Billion | ▼ -32.5% |
| 2020 | 0.44x | CN¥737.19 Million | CN¥343.16 Million | CN¥1.67 Billion | ▲ +37.8% |
| 2019 | 0.32x | CN¥469.30 Million | CN¥215.07 Million | CN¥1.46 Billion | ▲ +3.8% |
| 2018 | 0.31x | CN¥353.07 Million | CN¥243.19 Million | CN¥1.14 Billion | ▼ -5.2% |
| 2017 | 0.33x | CN¥67.65 Million | CN¥63.43 Million | CN¥207.73 Million | ▼ -90.7% |
| 2016 | 3.52x | CN¥81.71 Million | CN¥71.26 Million | CN¥23.23 Million | ▼ -10.2% |
| 2015 | 3.91x | CN¥126.02 Million | CN¥100.69 Million | CN¥32.19 Million | ▲ +27.8% |
| 2014 | 3.06x | CN¥136.56 Million | CN¥59.63 Million | CN¥44.60 Million | ▼ -5.8% |
| 2013 | 3.25x | CN¥109.50 Million | CN¥46.32 Million | CN¥33.70 Million | ▼ -51.8% |
| 2012 | 6.74x | CN¥180.00 Million | CN¥55.09 Million | CN¥26.72 Million | ▲ +360.5% |
| 2011 | 1.46x | CN¥32.73 Million | CN¥11.66 Million | CN¥22.37 Million | ▼ -37.4% |
| 2010 | 2.34x | CN¥37.70 Million | CN¥20.81 Million | CN¥16.12 Million | ▲ +155.2% |
| 2009 | 0.92x | CN¥32.11 Million | CN¥13.28 Million | CN¥35.04 Million | ▼ -43.1% |
| 2008 | 1.61x | CN¥46.03 Million | CN¥21.70 Million | CN¥28.57 Million | ▲ +144.9% |
| 2007 | 0.66x | CN¥28.64 Million | CN¥22.19 Million | CN¥43.53 Million | — |